Given that sickle cell disorder is currently the fastest growing genetic disorder in the UK, with nearly 300 babies born with the condition each year, it is appalling that we have gone backwards to a reliance on only one licensed NHS treatment.
This move means that with immediate effect, no new patients will be prescribed crizanlizumab, and those already on the drug need to discuss treatment options with their doctors.
[
add
]
[
|
|
...
]